Literature DB >> 17717629

The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties.

K B Helle1, A Corti, M H Metz-Boutigue, B Tota.   

Abstract

Chromogranin A (CgA) belongs to the granin family of uniquely acidic secretory proteins co-stored and co-secreted with other hormones and peptides in elements of the diffuse neuroendocrine system. The granins arise from different genes and are characterized by numerous sites for post-translational cleavage into shorter peptides with postulated regulatory properties. This review is directed towards endocrine aspects of CgA and its biologically active peptides. There is ample evidence from in vitro studies of distinct effects and targets for three CgA-derived peptides, vasostatin-I, pancreastatin and catestatin. Endocrine regulations are indicated from in vivo studies, consistent with the postulated prohormone function of CgA for peptides with regulatory properties. Most of the effects fit into patterns of direct or indirect, inhibitory modulations of major functions, implicating CgA peptides in regulation of calcium and glucose metabolism, cardiovascular functions, gastrointestinal motility and nociception, tissue repair, inflammatory responses and as host defense peptides in the first phase of microbial invasions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717629     DOI: 10.1007/s00018-007-7254-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  66 in total

1.  Reprint of: Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis.

Authors:  Hisatsugu Koshimizu; Taeyoon Kim; Niamh X Cawley; Y Peng Loh
Journal:  Regul Pept       Date:  2010-10-13

Review 2.  Catestatin: a multifunctional peptide from chromogranin A.

Authors:  Sushil K Mahata; Manjula Mahata; Maple M Fung; Daniel T O'Connor
Journal:  Regul Pept       Date:  2010-01-28

3.  Urine proteomics for profiling of human disease using high accuracy mass spectrometry.

Authors:  Alex Kentsis; Flavio Monigatti; Kevin Dorff; Fabien Campagne; Richard Bachur; Hanno Steen
Journal:  Proteomics Clin Appl       Date:  2009-09-01       Impact factor: 3.494

4.  The N-terminal fragment of chromogranin A, vasostatin-1 protects mice from acute or chronic colitis upon oral administration.

Authors:  Cristiano Rumio; Giuseppina F Dusio; Barbara Colombo; Anna Gasparri; Diego Cardani; Fabrizio Marcucci; Angelo Corti
Journal:  Dig Dis Sci       Date:  2012-01-26       Impact factor: 3.199

5.  Novel autoantigens in type 1 diabetes.

Authors:  Shuhong Han; William Donelan; Hai Wang; Westley Reeves; Li-Jun Yang
Journal:  Am J Transl Res       Date:  2013-05-24       Impact factor: 4.060

Review 6.  Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors.

Authors:  Guida M Portela-Gomes; Lars Grimelius; Mats Stridsberg
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

7.  High-resolution mass spectrometry analysis of protein oxidations and resultant loss of function.

Authors:  Stephen Barnes; Erin M Shonsey; Shannon M Eliuk; David Stella; Kerri Barrett; Om P Srivastava; Helen Kim; Matthew B Renfrow
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

Review 8.  Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis.

Authors:  Hisatsugu Koshimizu; Taeyoon Kim; Niamh X Cawley; Y Peng Loh
Journal:  Regul Pept       Date:  2009-12-16

9.  Long human CHGA flanking chromosome 14 sequence required for optimal BAC transgenic "rescue" of disease phenotypes in the mouse Chga knockout.

Authors:  Sucheta M Vaingankar; Ying Li; Angelo Corti; Nilima Biswas; Jiaur Gayen; Daniel T O'Connor; Sushil K Mahata
Journal:  Physiol Genomics       Date:  2009-12-15       Impact factor: 3.107

10.  Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease.

Authors:  Elisabetta Ferrero; Angelo Corti; Julien Haroche; Daniela Belloni; Barbara Colombo; Alvise Berti; Giulio Cavalli; Corrado Campochiaro; Antonello Villa; Fleur Cohen-Aubart; Zahir Amoura; Claudio Doglioni; Lorenzo Dagna; Marina Ferrarini
Journal:  Oncoimmunology       Date:  2016-05-05       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.